Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|November 21, 2022
Conformational deformation of a multi-jointed elastic loopHiro Tanaka, Yuji Seki, Shohei Ueno, et al.
Biocontrol Science|March 19, 2019
Construction of Its Evaluation System in Originally Designed Test-Chamber System and Sporicidal Activity of Aerosolized Hypochlorite Solution to Bacillus subtilis SporesShu Ishikawa, Shohei Ueno, Mai Mitsui, et al.
Frontiers in Cardiovascular Medicine|April 7, 2022
Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell TherapyShohei Moriyama, Mitsuhiro Fukata, Taku Yokoyama, et al.
Investigational New Drugs|November 18, 2021
Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancerHisanaga Nomura, Daiki Tsuji, Shohei Ueno, et al.
Molecular and Clinical Oncology|September 3, 2021
Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case reportShohei Ueno, Masato Uenomachi, Hitoshi Kusaba, et al.
BMC Surgery|May 13, 2022
Near infrared ray-guided surgery using Firefly technology of the daVinci Xi system and intraoperative upper gastrointestinal endoscopy for subtotal gastrectomy and surgery for cancer of the gastroesophageal junctionHiroyuki Sagawa, Masaki Saito, Sunao Ito, et al.
International Journal of Clinical Oncology|October 21, 2020
Safety and efficacy of S-1 plus oxaliplatin 130 mg/m<sup>2</sup> combination therapy in patients with previously untreated HER2-negative unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: a phase II trial (KSCC1501A)Tomomi Kashiwada, Katsunori Shinozaki, Shohei Ueno, et al.
Cancer Letters|February 12, 2022
Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusionsMamoru Ito, Michitaka Nakano, Hiroshi Ariyama, et al.
JCO Precision Oncology|May 15, 2024
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric CancerKyoko Yamaguchi, Mamoru Ito, Taichi Isobe, et al.
Anticancer Research|March 28, 2023
Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxelYasushi Ide, Taiga Otsuka, Mototsugu Shimokawa, et al.
Pageof 2